Intratumoral oncolytic virotherapy in pancreatic cancer: from feasibility to immune priming
Translational Gastroenterology and Hepatology · 2026-05 · 11 · 56-56
DOI: 10.21037/tgh-2026-0010 ↗Kurz gefasst
Editorial in der Zeitschrift Translational Gastroenterology and Hepatology, 2026-05. Verfasst von Tsutomu Nishida und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, Osaka, Japan. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
overall survival of 7.8 months—but also in its acceptable safety profile and demonstration of technical feasibility and biological plausibility. Intratumoral delivery via EUS has the potential to circumvent one of the central barriers in PDAC therapy, poor drug penetration due to stromal desmoplasia, while simultaneously providing a means to remodel the tumor immune microenvironment. However, the absence of objective responses warrants careful interpretation. T-VEC is designed to induce local viral replication, tumor cell lysis, and antigen release; however, these processes do not necessarily translate directly into measurable tumor shrinkage. In PDAC, even when local oncolysis and immune
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka, Osaka, Japan.
- Department of Gastroenterology and Hepatology, The University of Osaka Graduate School of Medicine, Suita, Osaka, Japan.
ORCID-Profile: Tsutomu Nishida, Yoshito Hayashi
Zitieren
APA
Nishida, T., & Hayashi, Y. (2026). Intratumoral oncolytic virotherapy in pancreatic cancer: from feasibility to immune priming. Translational Gastroenterology and Hepatology, 11, 56-56. https://doi.org/10.21037/tgh-2026-0010
Vancouver
Nishida T, Hayashi Y. Intratumoral oncolytic virotherapy in pancreatic cancer: from feasibility to immune priming. Translational Gastroenterology and Hepatology. 2026;11:56-56. doi:10.21037/tgh-2026-0010
BibTeX
@article{Nishida2026,
author = {Nishida, Tsutomu and Hayashi, Yoshito},
title = {Intratumoral oncolytic virotherapy in pancreatic cancer: from feasibility to immune priming},
journal = {Translational Gastroenterology and Hepatology},
year = {2026},
volume = {11},
pages = {56--56},
doi = {10.21037/tgh-2026-0010}
}
EUVIMED